Delivery Order SPE2DB20D1100-SPE2DB25FE0J5
Award Date 8/13/25
Potential Completion Date 8/14/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,986.33 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500 count) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price, competitively awarded delivery order represents a single pharmaceutical product shipment with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of CellCept 500 mg tablets (500-count units) with a ceiling value of $17,501.38. This firm fixed-price contract is a non-competitive child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for CellCept 500 mg tablets (100 count) valued at $1,283.84, with an award date of August 13, 2025, and ultimate completion by August 14, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of CellCept 500 mg tablets (100-count units) valued at $7,015.33. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $35,063.75 to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CellCept 500 mg tablets, a medication used to prevent organ rejection in transplant patients. The contract has a ceiling value of $21,122.46 and runs through February 2025. No set-aside designation is mentioned, indicating this was an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,177,785 units of the medication CellCept 500 mg tablet in 500-count containers. The contract has a firm fixed price of $33,780.80 and a performance period ending on May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a medication, with a ceiling value of $36,686.95. The contract has an ultimate completion date of April 3, 2025 and uses a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CellCept 500 mg tablets, a medication used for organ transplant patients. The contract has a firm fixed price of $8,292.86 and a period of performance through February 14, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELLCEPT 500 MG TABLET 500S, a prescription medication, with a firm fixed price of $73,153.83 and a performance period ending on June 24, 2025. The contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp is the prime contractor and does not...